News

The phase 2 EMPATHY top-line data which is a DARP in therapeutic antiviral used in the COVID-19 treatment suggests that measurable and meaningful benefits were seen from Ensovibep over the placebo. The trial is being conducted by Novartis and...

According to the forecast shared by WHO top officials more than half of Europe will suffer from the highly contagious variant of COVID-19, Omicron in the next couple of months. As per one of the top line directors at...

The year that has gone by has had a phenomenal impact on the way we perceive things around us. The pandemic, which is still evolving through its numerous variants, has taught us to think out of the box, and...

The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be reworked to ensure their effectiveness against not only Omicron but future variants as well that...

When it comes to cystic fibrosis, which is a debilitating and progressive condition found in around 11000 people in the UK, no cure has been attained. The EC- European Commission, as it has come to notice, has granted a...

SEEQC, which is a digital quantum computing company, and Oxford University have partnered to ensure accelerated use of computing based on the quantum method in the research particularly focused on pharmaceuticals. This collaboration has unfolded since the development time...

With questions being raised on the safety of the only available approved oral antiviral pill for COVID-19 - Molnupiravir, health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the...